300871 回盛生物
已收盘 08-14 15:00:00
资讯
新帖
简况
回盛生物(300871)6月30日股东户数1.93万户，较上期减少16.14%
证券之星 · 08-15 17:05
回盛生物(300871)6月30日股东户数1.93万户，较上期减少16.14%
图解回盛生物中报：第二季度单季净利润同比增长76.22%
证券之星 · 08-15 01:20
图解回盛生物中报：第二季度单季净利润同比增长76.22%
回盛生物（300871）披露2026年半年度报告，8月14日股价上涨5.0%
证券之星 · 08-14 22:21
回盛生物（300871）披露2026年半年度报告，8月14日股价上涨5.0%
回盛生物(300871.SZ)发布上半年业绩，归母净利润2.06亿元，同比增长75.59%
智通财经 · 08-14 17:33
回盛生物(300871.SZ)发布上半年业绩，归母净利润2.06亿元，同比增长75.59%
回盛生物（300871）披露为子公司提供担保的进展公告，8月11日股价上涨0.17%
证券之星 · 08-11
回盛生物（300871）披露为子公司提供担保的进展公告，8月11日股价上涨0.17%
股市必读：回盛生物新发布《关于为子公司提供担保的进展公告》
证券之星 · 08-10
股市必读：回盛生物新发布《关于为子公司提供担保的进展公告》
回盛生物（300871）披露为子公司提供担保的进展公告，8月7日股价上涨3.85%
证券之星 · 08-07
回盛生物（300871）披露为子公司提供担保的进展公告，8月7日股价上涨3.85%
回盛生物（300871）披露回购公司股份进展公告，8月3日股价上涨0.68%
证券之星 · 08-03
回盛生物（300871）披露回购公司股份进展公告，8月3日股价上涨0.68%
中航证券：给予回盛生物买入评级
证券之星 · 07-21
中航证券：给予回盛生物买入评级
回盛生物：公司经营基本面保持稳健
证券之星 · 07-14
回盛生物：公司经营基本面保持稳健
回盛生物涨6.31%，西南证券二个月前给出“买入”评级
证券之星 · 07-14
回盛生物涨6.31%，西南证券二个月前给出“买入”评级
回盛生物：泰乐菌素和泰万菌素原料价格受多种因素的影响
证券之星 · 07-10
回盛生物：泰乐菌素和泰万菌素原料价格受多种因素的影响
股市必读：回盛生物（300871）7月9日披露最新机构调研信息
证券之星 · 07-10
股市必读：回盛生物（300871）7月9日披露最新机构调研信息
回盛生物（300871）披露控股股东股权结构变动暨完成工商变更登记的提示性公告，7月1日股价上涨5.03%
证券之星 · 07-01
回盛生物（300871）披露控股股东股权结构变动暨完成工商变更登记的提示性公告，7月1日股价上涨5.03%
回盛生物（300871）披露为子公司提供担保的进展公告，6月29日股价上涨4.06%
证券之星 · 06-29
回盛生物（300871）披露为子公司提供担保的进展公告，6月29日股价上涨4.06%
回盛生物（300871）披露调整回购股份价格上限公告，6月26日股价下跌4.64%
证券之星 · 06-26
回盛生物（300871）披露调整回购股份价格上限公告，6月26日股价下跌4.64%
回盛生物（300871）披露为子公司提供担保的进展公告，6月23日股价上涨1.23%
证券之星 · 06-23
回盛生物（300871）披露为子公司提供担保的进展公告，6月23日股价上涨1.23%
回盛生物(300871.SZ)拟3000万元至6000万元回购公司股份
智通财经 · 06-08
回盛生物(300871.SZ)拟3000万元至6000万元回购公司股份
回盛生物最新公告：子公司获“格拉匹仑片”新兽药注册证书
证券之星 · 06-05
回盛生物最新公告：子公司获“格拉匹仑片”新兽药注册证书
回盛生物：公司取得的米氮平软膏已上市销售
证券之星 · 05-29
回盛生物：公司取得的米氮平软膏已上市销售
加载更多
公司概况
公司名称：
武汉回盛生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2020-08-24
主营业务：
武汉回盛生物科技股份有限公司的主营业务是兽用药品(包括化药制剂、原料药、中药制剂)、饲料及添加剂的研发、生产和销售。公司的主要产品是兽用药品（包括化药制剂、原料药、中药制剂）、饲料及添加剂。公司是农业产业化国家重点龙头企业。
发行价格：
33.61
{"stockData":{"symbol":"300871","market":"SZ","secType":"STK","nameCN":"回盛生物","latestPrice":24.37,"timestamp":1786691007000,"preClose":23.21,"halted":0,"volume":10196396,"delay":0,"changeRate":0.05,"floatShares":202000000,"shares":202000000,"eps":1.6936,"marketStatus":"已收盘","change":1.16,"latestTime":"08-14 15:00:00","open":23.19,"high":24.44,"low":22.82,"amount":242000000,"amplitude":0.0698,"askPrice":24.38,"askSize":204,"bidPrice":24.37,"bidSize":331,"shortable":0,"etf":0,"ttmEps":1.6936,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":23.21,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":25.53,"lowLimit":20.89,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":201784357,"isCdr":false,"pbRate":2.08,"roa":"--","peRate":14.389466,"roe":"3.51%","epsLYR":1.3349,"committee":-0.256497,"marketValue":4917000000,"turnoverRate":0.0505,"status":0,"floatMarketCap":4917000000},"requestUrl":"/m/hq/s/300871/","defaultTab":"news","newsList":[{"id":"2659182178","title":"回盛生物(300871)6月30日股东户数1.93万户，较上期减少16.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182178","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659182178?lang=zh_cn&edition=full","pubTime":"2026-08-15 17:05","pubTimestamp":1786784715,"startTime":"0","endTime":"0","summary":"证券之星消息，近日回盛生物披露，截至2026年6月30日公司股东户数为1.93万户，较3月31日减少3709.0户，减幅为16.14%。户均持股数量由上期的8780.0股增加至1.05万股，户均持股市值为23.1万元。在动物保健行业个股中，回盛生物股东户数低于行业平均水平，截至6月30日，动物保健行业平均股东户数为1.96万户。根据统计，回盛生物2026年3月31日至2026年6月30日，主力资金净流出2.08亿元，游资资金净流入1.36亿元，散户资金净流入7216.71万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081500012742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123790","title":"图解回盛生物中报：第二季度单季净利润同比增长76.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123790","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659123790?lang=zh_cn&edition=full","pubTime":"2026-08-15 01:20","pubTimestamp":1786728034,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物2026年中报显示，上半年度公司主营收入8.65亿元，同比上升5.2%；归母净利润2.06亿元，同比上升75.59%；扣非净利润1.42亿元，同比上升43.26%；其中2026年第二季度，公司单季度主营收入4.07亿元，同比下降3.88%；单季度归母净利润1.28亿元，同比上升76.22%；单季度扣非净利润6356.71万元，同比下降2.52%；负债率31.77%，投资收益60.52万元，财务费用183.98万元，毛利率35.72%。财报数据概要请见下图:本文数据来源于回盛生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081500001943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659190147","title":"回盛生物（300871）披露2026年半年度报告，8月14日股价上涨5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659190147","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659190147?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:21","pubTimestamp":1786717316,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，回盛生物报收于24.37元，较前一交易日上涨5.0%，最新总市值为49.17亿元。该股当日开盘23.19元，最高24.44元，最低22.82元，成交额达2.42亿元，换手率为5.05%。近日，武汉回盛生物科技股份有限公司披露2026年半年度报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400040305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415117","title":"回盛生物(300871.SZ)发布上半年业绩，归母净利润2.06亿元，同比增长75.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415117","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659415117?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:33","pubTimestamp":1786700008,"startTime":"0","endTime":"0","summary":"智通财经APP讯，回盛生物 发布2026年半年度报告，报告期内，公司实现营业收入8.65亿元，同比增长5.20%。实现归属于上市公司股东的净利润2.06亿元，同比增长75.59%。报告期，公司化药制剂销售收入较上年同期下降2.28%，兽用原料药销售收入较上年同期增长 13.56%。海外销售保持快速增长，同比增长72.79%。受成本优化及产品价格上涨共同影响，兽用原料药业务毛利率较上年同期提升14.91%。公司持续加大研发创新投入，研发费用同比增长70.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"回盛生物(300871.SZ)发布上半年业绩，归母净利润2.06亿元，同比增长75.59%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916210","title":"回盛生物（300871）披露为子公司提供担保的进展公告，8月11日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916210","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658916210?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:16","pubTimestamp":1786457779,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，回盛生物报收于23.18元，较前一交易日上涨0.17%，最新总市值为46.77亿元。该股当日开盘23.07元，最高23.47元，最低22.98元，成交额达1亿元，换手率为2.14%。回盛生物于近日披露《关于为子公司提供担保的进展公告》。本次担保在公司已审批的担保额度范围内，无需另行审议。截至公告日，公司实际担保总余额为21,818万元，占2025年经审计净资产的10.04%，均为合并报表范围内担保，无逾期及对外担保情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952608","title":"股市必读：回盛生物新发布《关于为子公司提供担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658952608?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:51","pubTimestamp":1786301470,"startTime":"0","endTime":"0","summary":"公司公告汇总：回盛生物就为全资子公司新疆回盛提供担保事项签署《借款变更协议》，担保金额由3亿元调减至2亿元，仍在已审批额度内，无需另行审议。近日，双方签署《借款变更协议》，将原借款本金由人民币叁亿元变更为贰亿元，公司担保金额相应变更为人民币贰亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657447606","title":"回盛生物（300871）披露为子公司提供担保的进展公告，8月7日股价上涨3.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657447606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657447606?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:38","pubTimestamp":1786113501,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，回盛生物报收于22.95元，较前一交易日上涨3.85%，最新总市值为46.31亿元。公司于近日披露《关于为子公司提供担保的进展公告》。本次担保在公司已审批的担保额度范围内，无需再次提交董事会及股东会审议。被担保人新疆回盛为公司全资子公司，成立于2025年11月，目前处于建设期，尚未全面开展经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700041512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656272213","title":"回盛生物（300871）披露回购公司股份进展公告，8月3日股价上涨0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656272213","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656272213?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:51","pubTimestamp":1785750676,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，回盛生物报收于20.86元，较前一交易日上涨0.68%，最新总市值为42.09亿元。该股当日开盘20.72元，最高21.08元，最低20.61元，成交额达6226.01万元，换手率为1.48%。公司于近日披露《关于回购公司股份的进展公告》。公告显示，武汉回盛生物科技股份有限公司于2026年6月8日召开董事会，审议通过以集中竞价交易方式回购公司股份的议案，拟用于员工持股计划或股权激励。回购实施符合相关规定，后续将根据市场情况继续推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300024858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653271991","title":"中航证券：给予回盛生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2653271991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653271991?lang=zh_cn&edition=full","pubTime":"2026-07-21 18:54","pubTimestamp":1784631258,"startTime":"0","endTime":"0","summary":"中航证券有限公司彭海兰,陈翼近期对回盛生物进行研究并发布了研究报告《原料药量价齐升，宠物药开辟空间》，给予回盛生物买入评级。我们预计公司2026-2028年归母净利润分别为3.1亿元、4.0亿元、4.9亿元，EPS分别为1.53元、1.97元、2.43元，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。本文数据来源于中航证券有限公司，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100037822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651106331","title":"回盛生物：公司经营基本面保持稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2651106331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651106331?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:52","pubTimestamp":1784033524,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物(300871)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问下，股价从年初的38元，到现在的22元，是不是因为经营出战了问题？公司增购股份，现在没有动作了呢？回盛生物回复：尊敬的投资者，您好！股价受宏观环境、行业轮动、投资者情绪等多种因素影响，公司经营基本面保持稳健，将持续深耕主业、提质增效，提升公司竞争力与盈利能力。目前公司经营情况正常。公司已实施股份回购，截至6月30日已回购股份134.34万股，回购金额2,947.58万元，回购的相关进展情况请关注公司公告。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400046349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651175825","title":"回盛生物涨6.31%，西南证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2651175825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651175825?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:32","pubTimestamp":1784017968,"startTime":"0","endTime":"0","summary":"今日回盛生物涨6.31%，收盘报24.25元。2026年4月22日，西南证券研究员徐卿,赵磐发布了对回盛生物的研报《2025年年报点评：业绩创新高，原料药与新兴业务驱动高成长》，该研报对回盛生物给出“买入”评级。研报中预计2026-2028年EPS分别为1.65元、1.97元、2.47元，对应动态PE分别为17/14/11倍，维持“买入”评级。回盛生物个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650900537","title":"回盛生物：泰乐菌素和泰万菌素原料价格受多种因素的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2650900537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650900537?lang=zh_cn&edition=full","pubTime":"2026-07-10 15:18","pubTimestamp":1783667894,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，咨询几个问题：1、公司核心泰万、泰乐菌素原料药目前市场供需、出厂报价走势如何？泰乐菌素和泰万菌素原料价格受多种因素的影响，公司根据市场情况动态调整产品价格。今年养殖行业景气度较低，兽药需求受到一定影响，根据公开市场信息，原料药泰万菌素、泰乐菌素价格有所下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000021282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650979702","title":"股市必读：回盛生物（300871）7月9日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2650979702","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650979702?lang=zh_cn&edition=full","pubTime":"2026-07-10 02:45","pubTimestamp":1783622712,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，回盛生物报收于22.79元，下跌1.04%，换手率3.61%，成交量7.29万手，成交额1.66亿元。机构调研要点：公司于7月9日召开业绩说明会，披露2025年获7个新兽药证书，并推进美国DMF备案、欧洲CEP认证及越南生产基地投产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000001533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648511907","title":"回盛生物（300871）披露控股股东股权结构变动暨完成工商变更登记的提示性公告，7月1日股价上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511907","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648511907?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:52","pubTimestamp":1782899526,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，回盛生物报收于23.17元，较前一交易日上涨5.03%，最新总市值为46.75亿元。近日，回盛生物发布《关于控股股东股权结构变动暨完成工商变更登记的提示性公告》。本次转让系控股股东内部股权结构调整，不涉及上市公司层面股份变动。转让后，武汉统盛持有回盛生物82,800,000股，持股比例仍为41.03%，公司控股股东仍为武汉统盛，实际控制人仍为张卫元、余姣娥。相关工商变更登记已完成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100034732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370252","title":"回盛生物（300871）披露为子公司提供担保的进展公告，6月29日股价上涨4.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647370252?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:26","pubTimestamp":1782743183,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，回盛生物报收于23.09元，较前一交易日上涨4.06%，最新总市值为46.59亿元。该股当日开盘21.95元，最高23.35元，最低21.48元，成交额达2.2亿元，换手率为4.82%。本次担保在公司已审批的担保额度范围内，无需再次履行审议程序。截至2026年3月31日，其资产总额为167,759.40万元，净资产为119,676.55万元。本次担保后，公司实际担保余额为17,979.25万元，占2025年经审计净资产的8.27%，均为合并报表范围内担保，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365944","title":"回盛生物（300871）披露调整回购股份价格上限公告，6月26日股价下跌4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646365944?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:38","pubTimestamp":1782484702,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，回盛生物报收于22.19元，较前一交易日下跌4.64%，最新总市值为44.78亿元。该股当日开盘22.98元，最高23.07元，最低21.99元，成交额达1.63亿元，换手率为3.62%。近日，武汉回盛生物科技股份有限公司发布《关于调整回购股份价格上限的公告》。根据相关规定，自2026年7月6日起，回购股份价格上限由不超过37.20元/股调整为不超过37.00元/股。本次调整系因权益分派除权除息所致，其他回购事项无变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645887592","title":"回盛生物（300871）披露为子公司提供担保的进展公告，6月23日股价上涨1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645887592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645887592?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:53","pubTimestamp":1782208386,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，回盛生物报收于23.04元，较前一交易日上涨1.23%，最新总市值为46.49亿元。该股当日开盘22.6元，最高23.66元，最低22.51元，成交额达1.72亿元，换手率为3.66%。本次担保在公司已审批的担保额度范围内，无需提交董事会或股东会审议。截至目前，公司实际提供担保总余额为15,979.25万元，占2025年经审计净资产的7.35%，均为合并报表范围内担保，无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300031225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100523","title":"回盛生物(300871.SZ)拟3000万元至6000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641100523?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:04","pubTimestamp":1780909442,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 回盛生物(300871.SZ)发布公告，公司拟使用自有资金以集中竞价交易方式回购本公司部分社会公众股，回购股份的资金总额不低于人民币3000万元(含)，不超过人民币6000万元(含)，回购价格不超过人民币37.20元/股(含)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111539","title":"回盛生物最新公告：子公司获“格拉匹仑片”新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641111539?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:42","pubTimestamp":1780652526,"startTime":"0","endTime":"0","summary":"回盛生物(300871.SZ)公告称，公司子公司湖北回盛生物科技有限公司与其他单位联合申报的“格拉匹仑片”获农业农村部批准为新兽药，并核发《新兽药注册证书》。该药为国产首款新靶点宠物专用解热镇痛药，用于控制犬骨关节炎的疼痛和炎症，安全性更高，适合长期使用。产品待取得兽药产品批准文号后上市，短期内不会对业绩产生重要影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500030813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639610857","title":"回盛生物：公司取得的米氮平软膏已上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2639610857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639610857?lang=zh_cn&edition=full","pubTime":"2026-05-29 08:54","pubTimestamp":1780016052,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物(300871)05月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司研发的，猫传染性腹膜炎、犬骨关节炎领域新药和米氮平软膏等5款宠物新药，预计什么时候或已经上市销售了吗？回盛生物回复：尊敬的投资者，您好！公司取得的米氮平软膏已上市销售。宠物医疗是公司战略业务之一。公司拥有独立、专业化的宠物药品研发团队，宠物产品覆盖抗感染、抗寄生虫、抗真菌、镇静止痛、皮肤病和耳药等宠物疾病。公司正加快宠物药品板块布局，利用自身在研发创新方面的优势，丰富产品矩阵，打造新的业务增长极。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900008562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786835406789,"stockEarnings":[{"period":"1week","weight":0.0619},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.02},{"period":"6month","weight":-0.0835},{"period":"1year","weight":0.1237},{"period":"ytd","weight":0.1854}],"compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0072},{"period":"3month","weight":-0.0503},{"period":"6month","weight":-0.0379},{"period":"1year","weight":0.0711},{"period":"ytd","weight":-0.0105}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉回盛生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19274人(较上一季度减少16.14%)","perCapita":"10469股","listingDate":"2020-08-24","address":"湖北省武汉市东西湖区新沟街道办事处油纱路52号","registeredCapital":"20178万元","survey":" 武汉回盛生物科技股份有限公司的主营业务是兽用药品(包括化药制剂、原料药、中药制剂)、饲料及添加剂的研发、生产和销售。公司的主要产品是兽用药品（包括化药制剂、原料药、中药制剂）、饲料及添加剂。公司是农业产业化国家重点龙头企业。","listedPrice":33.61},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"回盛生物(300871)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供回盛生物(300871)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"回盛生物,300871,回盛生物股票,回盛生物股票老虎,回盛生物股票老虎国际,回盛生物行情,回盛生物股票行情,回盛生物股价,回盛生物股市,回盛生物股票价格,回盛生物股票交易,回盛生物股票购买,回盛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"回盛生物(300871)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供回盛生物(300871)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}